CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-18 | Liu David Y Chief Scientific Officer | Sale | −875 | $20.00 | $18K | 3,822 |
| 2017-12-18 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −875 | 11,475 | ||
| 2017-12-18 | O'Neil Thomas P. Chief Financial Officer | Option exercise | +4,000 | $1.16 | $5K | 4,000 |
| 2017-12-18 | O'Neil Thomas P. Chief Financial Officer | Option exercise | +4,000 | $4.21 | $17K | 8,000 |
| 2017-12-18 | O'Neil Thomas P. Chief Financial Officer | Sale | −8,000 | $20.00 | $160K | 0 |
| 2017-12-18 | O'Neil Thomas P. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −4,000 | 57,666 | ||
| 2017-12-18 | O'Neil Thomas P. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −4,000 | 28,998 | ||
| 2017-12-15 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2017-12-15 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2017-11-30 | Liu David Y Chief Scientific Officer | Grant or award | +875 | $1.89 | $2K | 4,697 |
| 2017-11-30 | Liu David Y Chief Scientific Officer | Sale | −875 | $20.00 | $18K | 3,822 |
| 2017-11-30 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −875 | 12,350 | ||
| 2017-11-13 | Liu David Y Chief Scientific Officer | Option exercise | +3,500 | $4.21 | $15K | 7,322 |
| 2017-11-13 | Liu David Y Chief Scientific Officer | Sale | −3,500 | $16.97 | $59K | 3,822 |
| 2017-11-13 | Liu David Y Chief Scientific Officer | Option exercise | +3,500 | $1.89 | $7K | 7,322 |
| 2017-11-13 | Liu David Y Chief Scientific Officer | Sale | −3,500 | $16.97 | $59K | 3,822 |
| 2017-11-13 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −3,500 | 38,831 | ||
| 2017-11-13 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −3,500 | 13,225 | ||
| 2017-10-05 | Shames Richard S. Chief Medical Officer | Option exercise | +2,017 | $4.21 | $8K | 2,017 |
| 2017-10-05 | Shames Richard S. Chief Medical Officer | Sale | −2,017 | $19.00 | $38K | 0 |
Page 26 of 29 · 580 trades